Association between cardiovascular risk factors and stage 1 hypertension defined by the 2017 ACC/AHA guidelines

Xing Zhen Liu1, Dong Shui Chen1, Fu Ping Di1

  • 1The First Convalescence Area, Hangzhou Aeronautical Sanatorium of Chinese Air Force , Hangzhou, China.

Insights

Stage 1 hypertension (130-139/80-89 mmHg) in China is linked to higher cardiovascular risk factors. Targeted interventions for abdominal obesity, elevated fasting plasma glucose, and high triglycerides are crucial for managing this condition.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • The 2017 ACC/AHA guidelines define stage 1 hypertension as 130-139/80-89 mmHg.
  • This definition impacts a significant portion of the adult population.
  • Understanding associated cardiovascular risk factors (CRFs) is vital for public health strategies in China.

Purpose of the Study:

  • To investigate the association between CRFs and newly defined stage 1 hypertension in the Chinese adult population.
  • To identify specific CRFs that contribute to stage 1 hypertension.
  • To inform targeted interventions for hypertension prevention and management.

Main Methods:

  • Analysis of data from 84,489 adults with blood pressure <140/90 mmHg.
  • Calculation of 10-year cardiovascular disease (CVD) risk using the China-PAR equation.
  • Logistic regression analysis to determine the association between CRFs and stage 1 hypertension.

Main Results:

  • Individuals with stage 1 hypertension (130-139/80-89 mmHg) exhibited higher mean CRFs, metabolic abnormalities, and 10-year CVD risk compared to those with lower BP.
  • Increased odds of stage 1 hypertension were significantly associated with waist circumference (OR 1.362), fasting plasma glucose (OR 1.264), and triglycerides (OR 1.331).
  • Other CRFs did not show a significant association with stage 1 hypertension in this cohort.

Conclusions:

  • Stage 1 hypertension in China is associated with a clustering of cardiovascular risk factors.
  • Abdominal obesity, elevated fasting plasma glucose, and hypertriglyceridemia are key modifiable risk factors.
  • Multidisciplinary and targeted interventions are necessary to manage these CRFs in individuals with stage 1 hypertension.
Abstract

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
601
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
644
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
507
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
385
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
6.2K